Search

Your search keyword '"Tabata, Kaori"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Tabata, Kaori" Remove constraint Author: "Tabata, Kaori"
41 results on '"Tabata, Kaori"'

Search Results

1. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

2. Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case

3. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236

4. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

5. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

7. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

8. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236

9. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

13. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

14. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

15. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay

16. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

17. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

20. List of Contributors

21. Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution

25. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay

28. Determination of cell fate in skeletal muscle following BMP gene transfer by in vivo electroporation

35. Immunochemical Analysis of the Antimalarial Drugs Artemisinin and Artesunate

37. Preparation of a Single-Chain Variable Fragment and a Recombinant Antigen-Binding Fragment against the Anti-Malarial Drugs, Artemisinin and Artesunate, and Their Application in an ELISA

41. Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.

Catalog

Books, media, physical & digital resources